Analyze Diet
The Veterinary record2025; e5499; doi: 10.1002/vetr.5499

Review of published research on primary dysautonomia of domestic animals.

Abstract: An article published in 1992 by Marion M. Pollin and I.R. Griffiths reviewed the topic of primary dysautonomias of the autonomic nervous system of unidentified origin in multiple domestic species, specifically cats, dogs and horses. Thirty-one years later, we appear no closer to identifying the causal agents of these strikingly similar diseases. This article reviews the similarities and differences in clinical presentation and pathology of dysautonomia in canids, felids, equids, leporids and other less frequently reported species.
Publication Date: 2025-06-07 PubMed ID: 40482055DOI: 10.1002/vetr.5499Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper is a review of studies related to primary dysautonomia in domestic animals such as cats, dogs, and horses. The paper compares the symptoms and causes of this dysfunction across different species.

Understanding Primary Dysautonomia

Dysautonomia refers to disorders of the autonomic nervous system, the system that manages the body’s internal functions such as heart rate and digestion. Primary dysautonomia implies that the disorder has no identifiable underlying cause. This review paper focuses on this type of disorder in domestic animals. Despite decades of research, the paper notes a lack of progress in identifying the causes of these disorders across species.

  • At the heart of the research is a comparison of the clinical presentation and pathology of the disorder across dogs (canids), cats (felids), horses (equids), rabbits (leporids), and other less frequently studied species.
  • By identifying similarities and differences, the authors aim to gain a deeper understanding of why these disorders occur and how they might be treated.

An Overview of Past Studies

In their review, Marion M. Pollin and I.R. Griffiths reference a study published in 1992 that was, at the time, the most comprehensive work on this topic.

  • They emphasize, however, that no substantial progress has been made in the nearly three decades since then in identifying the causes of primary dysautonomia.
  • The sessions of this disorder across different animal species are strikingly similar. Therefore, the authors suggest that there may be a common cause or set of causes for these disorders.

Implications for Future Research

The paper proposes several avenues for future research based on the patterns identified in the review.

  • This cross-species analysis could be useful in developing new experimental models for studying the disorder.
  • If certain species are more prone to developing primary dysautonomia, they could serve as models for studying the disorder in other species, including humans.
  • The similarities in the clinical presentation and pathology of these disorders suggest that they may share at least some common causes. Identifying these could be a significant step towards developing effective treatments.

Cite This Article

APA
Harte T, Smith D, Moore J, Wells B. (2025). Review of published research on primary dysautonomia of domestic animals. Vet Rec, e5499. https://doi.org/10.1002/vetr.5499

Publication

ISSN: 2042-7670
NlmUniqueID: 0031164
Country: England
Language: English
Pages: e5499

Researcher Affiliations

Harte, Tanith
  • Moredun Research Institute, Penicuik, Midlothian, UK.
Smith, David
  • Moredun Research Institute, Penicuik, Midlothian, UK.
Moore, Jo
  • Moredun Research Institute, Penicuik, Midlothian, UK.
Wells, Beth
  • Moredun Research Institute, Penicuik, Midlothian, UK.

Grant Funding

  • Equine Grass Sickness Fund
  • Moredun Foundation
  • Moredun Foundation Fellowship

References

This article includes 113 references
  1. Wehrwein EA, Orer HS, Barman SM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system.. Compr Physiol 2016;6(3):1239‒1278.
  2. Koopman FA, Stoof SP, Straub RH, van Maanen MA, Vervoordeldonk MJ, Tak PP. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis.. Mol Med 2011;17:937–948.
  3. Ghysen A. The origin and evolution of the nervous system.. Int J Dev Biol 2003;47:555–562.
  4. Lanigan LG, Russell DS, Woolard KD, Pardo ID, Godfrey V, Jortner BS. Comparative pathology of the peripheral nervous system.. Vet Pathol 2021;58:10–33.
  5. Olshansky B, Cannom D, Fedorowski A, Stewart J, Gibbons C, Sutton R. Postural orthostatic tachycardia syndrome (POTS): a critical assessment.. Prog Cardiovasc Dis 2020;63:263–270.
  6. Coon EA, Singer W, Low PA. Pure autonomic failure.. Mayo Clin Proc 2019;94:2087–2098.
  7. Li L, Gruner K, Tourtellotte WG. Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.. J Clin Invest 2020;130(5):2478–2487.
  8. Vernino S, Low PA, Fealey RD, Steward JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.. N Engl J Med 2000;343(12):847–855.
  9. Etienne M, Weimer LH. Immune‐mediated autonomic neuropathies.. Curr Neurol Neurosci Rep 2006;6:57–64.
  10. Potulska‐Chromik A, Zakrzewska‐Pniewska B, Szmidt‐Sałkowska E, Lewandowski J, Siński M, Przyjałkowski W. Long lasting dysautonomia due to botulinum toxin B poisoning: clinical‐laboratory follow up and difficulties in initial diagnosis.. BMC Res Notes 2013;6(1):438.
  11. Yuen JWY, Kim DD, Procyshyn RM, White RF, Honer WG, Barr AM. Clozapine‐induced cardiovascular side effects and autonomic dysfunction: a systematic review.. Front Neurosci 2018;12:203.
  12. Pollin MM, Griffiths IR. 1992 review of primary dysautonomias of domestic animals.. J Comp Pathol 1992;106:99–119.
  13. Berghaus RD, O'Brien DP, Thorne JG, Buening GM. Incidence of canine dysautonomia in Missouri, USA, between January 1996 and December 2000.. Prevent Vet Med 2002;54:291–300.
  14. Sharp NJH, Nash AS, Griffiths IR. Feline dysautonomia (the Key‒Gaskell syndrome): a clinical and pathological study of forty cases.. J Small Anim Pract 1984;25:599–615.
  15. Pirie RS, McGorum BC. Equine grass sickness: an update.. UK‐Vet Equine 2018;2(1):6–10.
  16. Mellor NE, Bladon B, Foote AK, O'Meara B. Successful treatment of chronic grass sickness in a donkey.. Equine Vet Educ 2013;25:628‒632.
  17. Wales AD, Blunden AS, Hosegood OM. Grass sickness with atypical presentation in a young zebra.. Vet Rec 2001;148(26):818‒819.
  18. Hahn CN, Whitwell KE, Mayhew IG. Neuropathological lesions resembling equine grass sickness in rabbits.. Vet Rec 2005;156(24):778–779.
  19. Griffiths IR, Whitwell KE. Leoprine dysautonomia—further evidence hares suffer from grass sickness.. Vet Rec 1993;132:376–377.
  20. Middleton JR, Johnson GC, Pardo I, Chigerwe M, O'Brien DP. Dysautonomia and salmonellosis in an 11‐year‐old female llama (Lama glama).. J Vet Intern Med 2006;20(1):213–216.
  21. Lewis CA, Bozynski CC, Johnson GC, Harral CM, Williams F, Tyler JW. Colonic impaction due to dysautonomia in an alpaca.. J Vet Intern Med 2009;23(5):1117–1122.
  22. Pruden SJ, Mcallister MM, Schultheiss PC, Christensen DE. Abomasal emptying defect of sheep may be an acquired form of dysautonomia.. Vet Pathol 2004;41:164–169.
  23. Wright A, Beard L, Bawa B, Bras J. Dysautonomia in a six‐year‐old mule in the United States.. Equine Vet J 2010;42(2):170–173.
  24. Reginer A, Vandevelde M, Thevenet A. Feline dysautonomia (the Key‒Gaskell syndrome): a case report in France and review of the literature.. Rev Med Vet 1987;138(10):793–798.
  25. Randleff‐Rasmussen PK, Leblond A, Cappelle J, Bontemps J, Belluco S, Popoff MR. Development of a clinical prediction score for detection of suspected cases of equine grass sickness (dysautonomia) in France.. Vet Res Commun 2018;42(1):19–27.
  26. Resetic N, Jorgensen AR, Husted L. Outbreak of equine grass sickness in Denmark—4 cases.. Pferdeheilkunde 2021;37(6):569–576.
  27. Flagstad A. Feline dysautonomia (Key‒Gaskell syndrome). A new disease of cats—now also in Denmark.. Danish Vet J 1985;68(8):433–436.
  28. Wlaschitz S, Url A. The first case of chronic grass sickness in Austria.. Wien Tierarztl Monatsschr 2004;91:42–45.
  29. Schwarz B, Brunthaler R, Hahn C, van den Hoven R. Outbreaks of equine grass sickness in Hungary.. Vet Rec 2012;170(3):75.
  30. Fulvio L, Jacopo C, Teresa MM, Marilena B, Alice B, Rodolfo G. Equine grass sickness in Italy: a case series study.. BMC Vet Res 2021;17(1):264.
  31. Wylie CE, Proudman CJ, McGorum BC, Newton JR. A nationwide surveillance scheme for equine grass sickness in Great Britain: results for the period 2000–2009.. Equine Vet J 2011;43(5):571‒579.
  32. Eser MW, Feige K, Hilbe M. Clinical signs and diagnosis of acute grass sickness in horses in Switzerland and in Southern Germany.. Pferdeheilkunde 2000;16(2):138‒143.
  33. Weltrich N, Hewicker‐Trautwein M, Barsnick R. Acute equine grass sickness in a two‐year‐old Warmblood stallion in Germany.. Pferdeheilkunde 2018;34(5):432‒438.
  34. McGorum BC, Kirk J. Equine dysautonomia (grass sickness) is associated with altered plasma amino acid levels and depletion of plasma sulphur amino acids.. Equine Vet J 2001;33(5):473‒477.
  35. Leendertse IP. A horse with grass sickness.. Tijdschr Diergeneeskd 1993;118(11):365–366.
  36. Protopapas KF, Spanoudes KAM, Diakakis NE, Brellou GD. Equine grass sickness in Cyprus: a case report.. Turk J Vet Anim Sci 2012;36(1):85–87.
  37. Melkova P, Cizek P, Ludvikova E, Bezdekova B. Equine grass sickness in the Czech Republic: a case report.. Vet Med 2014;59(3):137‒140.
  38. Uzal FA, Doxey DL, Robles CA, Woodman MP, Milne EM. Histopathology of the brain‐stem nuclei of horses with “Mal Seco”, an equine dysautonomia.. J Comp Pathol 1994;111:297–301.
  39. McGorum BC, Pirie RS. Equine dysautonomia.. Vet Clin North Am Equine Practice 2018;34:113–125.
  40. Lyle C, Pirie RS. Equine grass sickness.. In Pract 2009;31(1):26–32.
  41. Copas VEN, Durham AE, Stratford CH, McGorum BC, Waggett B, Pirie RS. In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non‐inflammatory causes of colic.. Vet Rec 2013;172(15):395.
  42. Long A, Nolen‐Walston R. Equine inflammatory markers in the twenty‐first century: a focus on serum amyloid A.. Vet Clin North Am Equine Practice 2020;36:147–160.
  43. Quéré E, Volmer C, Mespoulhès‐Rivière C. Standing gustatory papillae biopsy procedure for antemortem diagnosis of equine grass sickness.. J Am Vet Med Assoc 2024;262(2):201–208.
  44. Wright JA, Hodsont NP. Pathological changes in the brain in equine grass sickness.. J Comp Path 1988;98:247–252.
  45. Cottrell DF, McGorum BC, Pearson GT. The neurology and enterology of equine grass sickness: a review of basic mechanisms.. Neurogastroenterol Motil 1999;11:79–92.
  46. Holman HH, Gordon WS, Pattison IH. Observations on the pathology and histology of grass sickness in horses.. J Comp Pathol Therap 1944;54:97–107.
  47. Murray A, Pearson GT, Cottrell DF. Light microscopy of the enteric nervous system of horses with or without equine dysautonomia (grass sickness): its correlation with the motor effects of physostigmine.. Vet Res Commun 1997;21:507–520.
  48. Hahn C, Mayhew I, De Lahunta A. Central neuropathology of equine grass sickness.. Acta Neuropathol 2001;102(2):153–159.
  49. McGorum BC, Davey T, Dosi MCM, Keen JA, Morrison LR, Pirie RS. Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions.. Equine Vet J 2024;57(1):193–202.
  50. Perkins JD, Bowen IM, Else RW, Marr CM, Mayhew IG. Functional and histopathological evidence of cardiac parasympathetic dysautonomia in equine grass sickness.. Vet Rec 2000;146(9):246–250.
  51. Marrs J, Small J, Milne EM, John HA. Liver and biliary system pathology in equine dysautonomia (grass sickness).. J Vet Med Series A: Physiol Pathol Clin Med 2001;48(4):243–255.
  52. Edwards SE, Martz KE, Rogge A, Heinrich M. Edaphic and phytochemical factors as predictors of equine grass sickness cases in the UK.. Front Pharmacol 2010;1:122.
  53. Wylie CE, Shaw DJ, Fordyce FM, Lilly A, Pirie RS, McGorum BC. Equine grass sickness in Scotland: a case‒control study of environmental geochemical risk factors.. Equine Vet J 2016;48(6):779–785.
  54. Knight AP. Poisonous plants. Nutritional management of equine diseases and special cases.. Wiley; 2017. p. 119–188.
  55. Michl J, Modarai M, Edwards S, Heinrich M. Metabolomic analysis of Ranunculus spp. as potential agents involved in the etiology of equine grass sickness.. J Agric Food Chem 2011;59(18):10388–10393.
  56. Hutchinson L, Norrey J, Lockton A, Coulthard E. Small areas of wildflower grassland in urban areas support significant species richness and abundance of pollinating insects.. Entomol Gaz 2020;71(2):103–119.
  57. McGorum B, Chen Z, Glendinning L, Hunt L, Ivens A, Keen J. Equine grass sickness (a multiple systems neuropathy) is associated with alterations in the gastrointestinal mycobiome.. Anim Microbiome 2021;3(1):70.
  58. Wylie CE, Shaw DJ, Fordyce FM, Lilly A, McGorum BC. Equine grass sickness in Scotland: a case‒control study of signalment‐ and meteorology‐related risk factors.. Equine Vet J 2014;46(1):64–71.
  59. Wylie CE, Proudman CJ. Equine grass sickness: epidemiology, diagnosis, and global distribution.. Vet Clin North Am Equine Practice 2009;25:381–399.
  60. Doxey DL, Gilmour JS, Milne EM. A comparative study of normal equine populations and those with grass sickness (dysautonomia) in eastern Scotland.. Equine Vet J 1991;23(5):365–369.
  61. Nash AS, Griffiths IS, Sharp NJ. Key‒Gaskell syndrome—an autonomic polyganglionopathy.. Vet Rec 1982;111:307–308.
  62. Schrauwen E, Appeldoorn A, Lemmens P. Feline dysautonomia in Belgium.. Vet Rec 1987;121(9):203.
  63. Litschi B, Dieth V. Key‒Gaskell syndrome in a cat in Switzerland.. Schweiz Arch Tierheilkd 1989;131(3):133–141.
  64. Kidder AC, Johannes C, O'Brien DP, Harkin KR, Schermerhorn T. Feline dysautonomia in the Midwestern United States: a retrospective study of nine cases.. J Feline Med Surg 2008;10(2):130–136.
  65. Torres BBJ, Martins GC, Ferian PE, Martins BC, Rachid MA, Melo EG. Key‒Gaskell syndrome in Brazil: first case report.. Arq Bras Med Vet Zootec 2014;66(4):1046–1050.
  66. Beban HJ, Beban R, Lindsay RG, Bentall HP. A suspected case of feline dysautonomia.. N Z Vet J 1987;35(4):58.
  67. Cave TA, Knottenbelt C, Mellor DJ, Nunn F, Nart P, Reid SWJ. Outbreak of dysautonomia (Key‒Gaskell syndrome) in a closed colony of pet cats.. Vet Rec 2003;153(13):387–392.
  68. Brown V. Degeneration of autonomic nervous system in feline dysautonomia case [Internet].. Vet Times. 2008 [cited 2024 Apr 18].
  69. Guscetti F, Pospischil A, Läuchli C, Ehrensperger F. Pathomorphology of feline dysautonomia (Key‒Gaskell syndrome). Histologic, electron microscopic and immunohistologic findings in 4 cats.. Tierarztl Prax 1991;19(3):296–301.
  70. Sharp NJH, Nash AS, Griffiths IR. Feline dysautonomia (the Key‒Gaskell syndrome): a clinical and pathological study of forty cases.. J Small Anim Pract 1984;25:599–615.
  71. Sharp NJH. Factors relating to the aetiology and pathogenesis of feline and equine dysautonomias.. J Small Anim Pract 1987;28:397–400.
  72. Nunn F, Cave TA, Knottenbelt C, Poxton IR. Association between Key‒Gaskell syndrome and infection by Clostridium botulinum type C/D.. Vet Rec 2004;155:111‒115.
  73. Rochlitz I, Bennett A. Key‒Gaskell syndrome in a bitch.. Vet Rec 1983;112(26):614–615.
  74. Jamieson PM, Scudamore CL, Ruppert CE, Mauchline S, Simpson JW. Canine dysautonomia: two clinical cases.. J Small Anim Pract 2002;43(1):22–26.
  75. Schulze C, Schanen H, Pohlenz J. Canine dysautonomia resembling the Key‒Gaskell syndrome in Germany.. Vet Rec 1997;141(19):496–497.
  76. Adamama‐Moraitou KK, Brellou GD, Rallis TS, Zavros N, Pardali D, Dinopoulos A. Chronic progressive autonomic dysfunction in a dog.. J Vet Med Series A Physiol Pathol Clin Med 2006;53(2):81–84.
  77. Caines D, Pinard CL, Kruth S, Orr J, James F. Autonomic dysfunction in a Jack Russell terrier.. Can Vet J 2011;52(3):297–299.
  78. Hull NC, O'Toole D, Miller MM, Shoults H, Deck R, Jones W. Canine dysautonomia in a litter of Havanese puppies.. J Vet Diagn Invest 2015;27(5):627‒631.
  79. Johnson MD, Rankin AJ, Meekins JM. Diminished pupillary light reflexes, elevated third eyelids, and decreased tear production are commonly associated with canine dysautonomia.. J Am Vet Med Assoc 2023;261(11):1‒6.
  80. Berghaus RD, O'Brien DP, Johnson GC, Thorne JC. Risk factors for the development of dysautonomia in dogs.. J Am Vet Med Assoc 2001;218(8):1285‒1290.
  81. Niessen SJM, Eastwood J, Smyth JBA, Cherubini GB. Five cases of canine dysautonomia in England (2004 to 2006).. J Small Anim Pract 2007;48(6):346‒352.
  82. Gow A. Dysautonomia in a flat‐coated retriever.. Small Anim Med 2008;13(1):22‒27.
  83. Longshore RC, O'Brien DP, Johnson GC, Grooters AM, Kroll RA. Dysautonomia in dogs: a retrospective study.. J Vet Intern Med 1996;10(3):103‒109.
  84. Wise LA, Lappin MR. A syndrome resembling feline dysautonomia (Key‒Gaskell syndrome) in a dog.. J Am Vet Med Assoc 1991;198(12):2103‒2106.
  85. Harkin KR, Andrews GA, Nietfeld JC. Dysautonomia in dogs: 65 cases (1993‒2000).. J Am Vet Med Assoc 2002;220(5):633‒639.
  86. Oglesbee BL, Lord B. Gastrointestinal diseases of rabbits.. In: Oglesbee BL, Jenkins JR, Quesenberry KE, Carpenter JW, editors. Ferrets, rabbits, and rodents. 2012. p. 174–187.
  87. Whitwell KW, Needleham J. Mucoid enteropathy in rabbits‐ dysautonomia confirmed.. Vet Rec 1996;139(13):323–324.
  88. Huber D, Gudan Kurilj A, Šoštarić‐Zuckermann IC. A case of leporine dysautonomia from Croatia.. Acta Vet Brno 2022;72(1):118–123.
  89. Van der Hage MH, Dorrestein GN. Caecal impaction in the rabbit: relationships with dysautonomia.. World Rabbit Science Association. Proceedings of the 6th World Rabbit Congress. 1996;3:77–80.
  90. Reece WO, Erickson H, Goff JP, Uemura EE. Duke's physiology of domestic animals.. 13th ed. Wiley‐Blackwell; 2015.
  91. Giuliano EA. Equine ocular adnexal and nasolacrimal disease.. Equine ophthalmology. 2nd ed. Elsevier; 2011. p. 133–180.
  92. Thompson JW. The nerve supply to the nictitating membrane of the cat.. J Anat 1961;95(Pt 3):371–385.
  93. Evans HE, de Lahunta A. Miller's anatomy of the dog.. 4th ed. Elsevier Health Sciences; 2012. p. 576–577.
  94. Bardgett RD, Lovell RD, Hobbs PJ, Jarvis SC. Seasonal changes in soil microbial communities along a fertility gradient of temperate grasslands.. Soil Biol Biochem 1999;31:1021–1030.
  95. Contreras‐Aguilar MD, Lamy E, Escribano D, Cerón JJ, Tecles F, Quiles AJ. Changes in salivary analytes of horses due to circadian rhythm and season: a pilot study.. Animals 2020;10(9):1486.
  96. Cherrie MPC, Nichols G, Lo Iacono G, Sarran C, Hajat S, Fleming LE. Pathogen seasonality and links with weather in England and Wales: a big data time series analysis.. BMC Public Health 2018;18:1067.
  97. Girling SJ, Fraser MA, Richardson D, Harley J, Ireland JL, Naylor A. An acute outbreak of equine dysautonomia (equine grass sickness) in a group of eight Przewalski's horses (Equus ferus [caballus] przewalskii).. Equine Vet Educ 2017;29(7):358‒361.
  98. Vincze B, Varga M, Kutasi O, Zenke P, Szenci O, Baska F. Family aggregation analysis shows a possible heritable background of equine grass sickness (dysautonomia) in a Hungarian stud population.. Acta Vet Hung 2020;68(3):263‒268.
  99. Harkin KR, Nietfeld J, Fischer JR. Dysautonomia in a family of German shorthaired pointers.. J Am Anim Hosp Assoc 2002;38:55‒59.
  100. Pakozdy A, Challande‐Kathman I, Doherr M, Cizinauskas S, Wheeler SJ, Oevermann A. Retrospective study of salinomycin toxicosis in 66 cats.. Vet Med Int 2010;2010:1‒5.
  101. van der Linde‐Sipman JS, van den Ingh TS, van Nes JJ, Verhagen H, Kersten JG, Beynen AC. Salinomycin‐induced polyneuropathy in cats: morphologic and epidemiologic data.. Vet Pathol 1999;36:152‒156.
  102. Aleman M, Magdesian KG, Peterson TS, Galey FD. Salinomycin toxicosis in horses.. J Am Vet Med Assoc 2007;230(12):1822‒1826.
  103. Rollinson J, Taylor F, Chesney J. Salinomycin poisoning in horses.. Vet Rec 1987;121(6):126‒128.
  104. Peixoto PV, Nogueira VA, Gonzaléz AP, Tokarnia CH, França TN. Accidental and experimental salinomycin poisoning in rabbits.. Pesqui Vet Bras 2009;29(9):695‒699.
  105. Carvalho AQ, Wisser CS, Manfioletti GO, Rigo N, Cristani J, Traverso SD. Natural and experimental salinomycin poisoning associated with the use of florfenicol in pigs.. Pesqui Vet Bras 2022;42:e06839.
  106. Sharma AD, McCoy L, Jacobs E, Willey H, Behn JQ, Nguyen H. Engineering a 3D functional human peripheral nerve in vitro using the Nerve‐on‐a‐Chip platform.. Sci Rep 2019;9(1):8921.
  107. Goldsteen PA, Sabogal Guaqueta AM, Mulder PPMFA, Bos IST, Eggens M, van der Koog L. Differentiation and on axon‐guidance chip culture of human pluripotent stem cell‐derived peripheral cholinergic neurons for airway neurobiology studies.. Front Pharmacol 2022;13:991072.
  108. Faber MN, Smith D, Price DRG, Steele P, Hildersley KA, Morrison LJ. Development of bovine gastric organoids as a novel in vitro model to study host‒parasite interactions in gastrointestinal nematode infections.. Front Cell Infect Microbiol 2022;12:904606.
  109. Smith D, Price DRG, Burrells A, Faber MN, Hildersley KA, Chintoan‐Uta C. The development of ovine gastric and intestinal organoids for studying ruminant host‒pathogen interactions.. Front Cell Infect Microbiol 2021;11:733811.
  110. Zdyrski C, Gabriel V, Ospina O, Wickham H, Sahoo DK, Dao K. A multi‐tissue comparison and molecular characterization of canine organoids [Internet].. 2022.
  111. Tekes G, Ehmann R, Boulant S, Stanifer ML. Development of feline ileum‐ and colon‐derived organoids and their potential use to support feline coronavirus infection.. Cells 2020;9(9):2085.
  112. Eicher AK, Kechele DO, Sundaram N, Berns HM, Poling HM, Haines LE. Functional human gastrointestinal organoids can be engineered from three primary germ layers derived separately from pluripotent stem cells.. Cell Stem Cell 2022;29(1):36‒51.e6.
  113. Workman MJ, Mahe MM, Trisno S, Poling HM, Watson CL, Sundaram N. Engineered human pluripotent‐stem‐cell‐derived intestinal tissues with a functional enteric nervous system.. Nat Med 2017;23(1):49–59.

Citations

This article has been cited 0 times.